Attack on amyloid-β protein
Attack on amyloid-β protein
About this item
Full title
Attack on amyloid-β protein
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Nature (London), 2016-09, Vol.537 (7618), p.36-37
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
An antibody therapy markedly reduces aggregates of amyloid-β, the hallmark protein of Alzheimer's disease, and might slow cognitive decline in patients. Confirmation of a cognitive benefit would be a game-changer.
See Article
p.50
A prospect for amyloid-β-removal therapy
Aducanumab is a recombinant human monoclonal antibody that selecti...
Alternative Titles
Full title
Attack on amyloid-β protein
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1038_537036a
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1038_537036a
Other Identifiers
ISSN
0028-0836
E-ISSN
1476-4687
DOI
10.1038/537036a
How to access this item
Log in as a Library member
